Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to make an assessment of the potential merits of including rapid diagnostics as part of the five-year action plan for antimicrobial resistance.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom’s 2024 to 2029 antimicrobial resistance (AMR) national action plan (NAP), published in May 2024, highlights the importance of accurate diagnostic testing to guide effective antibiotic use and tackle antimicrobial resistance. Supporting clinicians to prescribe the right antimicrobials only to those that need them is a core commitment in the NAP. Outcome six of the UK’s AMR NAP specifically relates to supporting the development of diagnostic tests for infection.
NHS England is taking a multifactorial approach to improving the roll out of innovative rapid diagnostics, aligning to the commitments of the 2024 to 2029 AMR NAP. This includes reducing barriers for industry to support the development of diagnostic tests, identifying innovations, and increasing the evidence for putting those innovations into practice.
Sepsis has no specific diagnostic test, and presentation can vary, making it difficult to diagnose. In hospitals, clinicians are supported in recognising sepsis by using the National Early Warning Score, now used in 99% of acute trusts and 100% of ambulance trusts in England. To support clinical staff in primary and secondary care settings, the National Institute of Health and Care Excellence published updated national guidance in March 2024 on sepsis recognition, diagnosis, and early management.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help develop a dedicated diagnostic pathway for sepsis.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom’s 2024 to 2029 antimicrobial resistance (AMR) national action plan (NAP), published in May 2024, highlights the importance of accurate diagnostic testing to guide effective antibiotic use and tackle antimicrobial resistance. Supporting clinicians to prescribe the right antimicrobials only to those that need them is a core commitment in the NAP. Outcome six of the UK’s AMR NAP specifically relates to supporting the development of diagnostic tests for infection.
NHS England is taking a multifactorial approach to improving the roll out of innovative rapid diagnostics, aligning to the commitments of the 2024 to 2029 AMR NAP. This includes reducing barriers for industry to support the development of diagnostic tests, identifying innovations, and increasing the evidence for putting those innovations into practice.
Sepsis has no specific diagnostic test, and presentation can vary, making it difficult to diagnose. In hospitals, clinicians are supported in recognising sepsis by using the National Early Warning Score, now used in 99% of acute trusts and 100% of ambulance trusts in England. To support clinical staff in primary and secondary care settings, the National Institute of Health and Care Excellence published updated national guidance in March 2024 on sepsis recognition, diagnosis, and early management.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make it his policy to help develop a national Sepsis Registry using (a) interoperable and (b) patient-level data.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government understands the clear need for reliable data on sepsis. Currently, the Office for National Statistics publishes data on the number of death registrations where sepsis was the underlying cause of death, and where sepsis was mentioned anywhere on the death certificate, in England and Wales between 2001 and 2023. However, there is a lack of accurate estimates of incidence and prevalence of sepsis cases due to inconsistency in the definitions used to describe sepsis, and differences in coding between professionals and organisations in the United Kingdom.
A sepsis registry would use retrospective data collection. The Government is, instead, focusing on improving our understanding of the current prevalence of infections and suspected sepsis, including the up-to-date burden to the National Health Service. The Department is working with NHS England and the UK Health Security Agency to monitor trends in infection incidence and the infection burden in secondary care, which are complex, multifactorial issues.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of introducing mechanisms to support the (a) adoption and (b) clinical systems integration of (i) novel and (ii) rapid diagnostics into clinical pathways.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Elective Reform Plan (ERP), published in January 2025, sets out the productivity and reform efforts needed to return to the 18-week standard, including reforms to diagnostic care to reduce waiting times for tests and scans.
The plan announced that integrated care boards (ICBs) will make optimal use of the new diagnostic capacity by increasing direct referrals and rolling out at least 10 straight-to-test pathways by March 2026. NHS England is working with clinicians to best determine priority pathways and implementation based on population need and where there is a clear opportunity for improving timescales and journeys to diagnosis.
The National Institute for Health and Care Excellence (NICE) issues authoritative, evidence-based guidance for the National Health Service on best practice that often includes recommendations to support diagnosis. NICE also develops guidance on new, innovative diagnostic technologies that helps people in the NHS make efficient, cost-effective and consistent decisions about adopting new products.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the NHS Central Alerting System notification entitled Shortage of Pancreatic enzyme replacement therapy (PERT) - Additional actions, published on 18 December 2024, what steps his Department his taking with the devolved Administrations to tackle shortages in pancreatic enzyme replacement therapies.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department has worked in close partnership with the devolved administrations in the management of this supply issue. The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this work, we have managed to secure additional volumes of PERT for 2025 for the UK. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market.
In December 2024, the Department issued further management advice to healthcare professionals, which was then discussed with and cascaded to all the devolved administrations. This directs clinicians to consider these unlicensed imports when licensed stock is unavailable, and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department, in collaboration with NHS England, has created a webpage to include the latest updates on PERT availability and easily accessible advice on the prescribing and ordering of alternative PERT products.
The Department has frequent conversations with representatives from the impacted patient groups, so that they are informed of the supply situation and the mitigation actions being taken.
The Department will also continue to meet with suppliers, patient groups, and other relevant stakeholders across the supply chain to provide updates on the supply position and the actions being taken to address them.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of Professor Mary Renfrew's report entitled Enabling Safe Quality Midwifery Services and Care In Northern Ireland, published on 22 October 2024.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Improving maternity and neonatal care remains a priority for the Government. Whilst health is a devolved matter, there will be shared challenges and opportunities for improvement, so we are considering the report to help inform our next steps. A formal assessment of the report has not been made to date.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 October 2024 to Question 10393 on NHS, whether the Health Minister in each devolved Administration is a working level contact.
Answered by Andrew Gwynne
An interministerial group meeting is currently being diarised for December 2024. At this meeting, all of the Health Ministers from across the United Kingdom will convene to discuss the 10-Year Health Plan in further detail, including any opportunities for alignment and information sharing across the UK.
Asked by: Robin Swann (Ulster Unionist Party - South Antrim)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to his Department's press release entitled Government issues rallying cry to the nation to help fix NHS, published on 21 October 2024, whether he plans to have discussions with the devolved Administrations on the future of the NHS.
Answered by Andrew Gwynne
Department officials working on the 10-Year Health Plan have had, and will continue to have, meetings with working level contacts in each of the devolved administrations. These conversations will continue to explore how best to identify potential areas of United Kingdom-wide policy alignment, as the plan is developed.